844 related articles for article (PubMed ID: 26280535)
1. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.
Herranz N; Gallage S; Mellone M; Wuestefeld T; Klotz S; Hanley CJ; Raguz S; Acosta JC; Innes AJ; Banito A; Georgilis A; Montoya A; Wolter K; Dharmalingam G; Faull P; Carroll T; Martínez-Barbera JP; Cutillas P; Reisinger F; Heikenwalder M; Miller RA; Withers D; Zender L; Thomas GJ; Gil J
Nat Cell Biol; 2015 Sep; 17(9):1205-17. PubMed ID: 26280535
[TBL] [Abstract][Full Text] [Related]
2. TORn about SASP regulation.
Herranz N; Gallage S; Gil J
Cell Cycle; 2015; 14(24):3771-2. PubMed ID: 26697828
[No Abstract] [Full Text] [Related]
3. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
4. mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership.
Cayo A; Segovia R; Venturini W; Moore-Carrasco R; Valenzuela C; Brown N
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360912
[TBL] [Abstract][Full Text] [Related]
5. Translating the effects of mTOR on secretory senescence.
Tomimatsu K; Narita M
Nat Cell Biol; 2015 Oct; 17(10):1230-2. PubMed ID: 26419801
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin and the inhibition of the secretory phenotype.
Wang R; Sunchu B; Perez VI
Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
[TBL] [Abstract][Full Text] [Related]
7. Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
Halicka HD; Zhao H; Li J; Lee YS; Hsieh TC; Wu JM; Darzynkiewicz Z
Aging (Albany NY); 2012 Dec; 4(12):952-65. PubMed ID: 23363784
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
9.
Woo J; Shin S; Ji H; Ryu D; Cho E; Kim Y; Kim J; Park D; Jung E
Nutrients; 2022 May; 14(9):. PubMed ID: 35565945
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K/Akt/mTOR pathway and induces senescent cell death by regulation of Bax/Bcl-2 pathway.
Kumar R; Sharma A; Kumari A; Gulati A; Padwad Y; Sharma R
Biogerontology; 2019 Apr; 20(2):171-189. PubMed ID: 30456590
[TBL] [Abstract][Full Text] [Related]
11. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.
Georgilis A; Klotz S; Hanley CJ; Herranz N; Weirich B; Morancho B; Leote AC; D'Artista L; Gallage S; Seehawer M; Carroll T; Dharmalingam G; Wee KB; Mellone M; Pombo J; Heide D; Guccione E; Arribas J; Barbosa-Morais NL; Heikenwalder M; Thomas GJ; Zender L; Gil J
Cancer Cell; 2018 Jul; 34(1):85-102.e9. PubMed ID: 29990503
[TBL] [Abstract][Full Text] [Related]
12. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
13. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence.
Liu Y; Hawkins OE; Su Y; Vilgelm AE; Sobolik T; Thu YM; Kantrow S; Splittgerber RC; Short S; Amiri KI; Ecsedy JA; Sosman JA; Kelley MC; Richmond A
EMBO Mol Med; 2013 Jan; 5(1):149-66. PubMed ID: 23180582
[TBL] [Abstract][Full Text] [Related]
14. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.
Coppé JP; Patil CK; Rodier F; Krtolica A; Beauséjour CM; Parrinello S; Hodgson JG; Chin K; Desprez PY; Campisi J
PLoS One; 2010 Feb; 5(2):e9188. PubMed ID: 20169192
[TBL] [Abstract][Full Text] [Related]
15. Redox and mTOR-dependent regulation of plasma lamellar calcium influx controls the senescence-associated secretory phenotype.
Chandrasekaran A; Lee MY; Zhang X; Hasan S; Desta H; Tenenbaum SA; Melendez JA
Exp Biol Med (Maywood); 2020 Nov; 245(17):1560-1570. PubMed ID: 32686475
[TBL] [Abstract][Full Text] [Related]
16. Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression.
van Vliet T; Varela-Eirin M; Wang B; Borghesan M; Brandenburg SM; Franzin R; Evangelou K; Seelen M; Gorgoulis V; Demaria M
Mol Cell; 2021 May; 81(9):2041-2052.e6. PubMed ID: 33823141
[TBL] [Abstract][Full Text] [Related]
17. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
Lau L; Porciuncula A; Yu A; Iwakura Y; David G
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157
[TBL] [Abstract][Full Text] [Related]
19. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
20. A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal.
Mastri M; Tracz A; Lee CR; Dolan M; Attwood K; Christensen JG; Liu S; Ebos JML
Cell Rep; 2018 Dec; 25(13):3706-3720.e8. PubMed ID: 30590043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
